Congressional Oversight & Investigations

Our bipartisan Congressional Oversight team brings substantial experience to bear when helping individuals, associations and businesses facing congressional scrutiny both navigate the policy, process and politics unique to congressional investigations and prepare for and mitigate collateral legal and reputational risks. We also have a history of strong relationships with lawmakers and boast an enviable record of success for our clients engaged in the congressional oversight process. We advise and support clients through the full range of congressional oversight activities—whether it means resolving a preliminary or narrow probe quickly and without adverse publicity or preparing company executives for high-stakes testimony before multiple Congressional committees under a politically charged spotlight and at the top of an ongoing daily news cycle.

Bipartisan and Multilevel Experience: Our team includes a former US Senator, the former Chief Investigator for the Ways & Means and Financial Services Committees, former senior officials in Democratic and Republican administrations, former congressional investigators, former federal prosecutors, and former senior staffers for congressional committees active in oversight and investigations.

Cross-Disciplinary and Collegial Responsiveness: We anticipate and address the rapidly changing dynamics of congressional investigations by closely coordinating with our White Collar Defense & Investigations, Commercial Litigation, Crisis Management & Strategic Response, and Legislative & Public Policy teams, as well as with our clients' internal teams and outside consultants.

Problem-Solving, Nonpolitical Focus: Our range of experience on the Hill as investigators, in Republican and Democratic administrations responding to investigations, and in numerous courtrooms makes us a smart choice for the gamut of individuals, associations, nonprofits, and corporations involved in high-stakes hearings and investigations in the House and Senate.

Experience Highlights

  • Life science companies and private equity investment firms in oversight hearings and congressional inquiries regarding COVID-19 responses.
  • Bill Taylor, a former US ambassador, in congressional testimony in connection with the 2019 presidential impeachment proceedings.
  • State Department official for testimony in connection with the 2019 presidential impeachment investigation.
  • Lisa Page, a former senior FBI official, before the House Judiciary and House Oversight and Reform Committees and Senate Select Committee on Intelligence regarding the bureau's investigations into Hillary Clinton's email server and Russian interference in the US election.
  • Global furniture retailer in responding to congressional inquiries into consumer safety policies at issue in concurrent litigation.
  • Nonprofit veterans service organization in connection with a Senate committee investigation into corporate governance and program expenditures.
  • Global pharmaceutical company in responding to multiple House and Senate investigations into drug pricing and in preparing the CEO and other company officials for congressional testimony
  • Retailer as subject of concurrent congressional and investigative journalist inquiries into cosmetic product safety.
  • Ambassador Geoffrey Pyatt in his appearance before the Senate Homeland Security Committee investigation of alleged conflicts of interest
  • Major art auction house and private art dealer in connection with an investigation into the art market conducted by the Senate Permanent Subcommittee on Investigations.
Subscribe
Subscribe Link

Email Disclaimer